Bergstrom Nutrition's methylsulfonylmethane (MSM) product, OptiMSM, has been awarded the new “Informed-Ingredient” certification created to help sports nutrition ingredients suppliers prove their quality credentials.
A campaign by the Danish Food Administration is seeking to curb misleading marketing of dietary supplements in retail stores, with random inspections and fines for the worst offenders.
Researchers have associated methylsulfonylmethane, or MSM, to
protecting articular cartilage and reducing inflammation in
osteoarthritis - findings that could bolster the profile of the
ingredient for joint health.
A working group set up by standards developer AOAC has issued a
call for analytical methods for joint supplement MSM, or
methylsufonyl methane, as part of the program to create validated
testing systems for 20 major supplements.
Rising consumer demand for non-prescription jointcare remedies,
backed up by new research out this year, will create a positive
climate for growth of newer entrants to the joint health sector,
believes UK company Gee Lawson.
Cardinal Nutrition has completed a year-long program of plant
expansions and process improvements, which has resulted in it being
able to offer continuously distilled MSM (methylsulfonylmethane) in
larger lots.
The recent safety scandal over Vioxx and the withdrawal of the drug
from the market left a huge void in the joint care market. But
manufacturers of natural products have been jumping in with both
feet, eager to prove the safety and...
Anti-inflammatory MSM (methylsulfonylmethane) has added to the
store of evidence pointing to its health benefits with a new study
suggesting that it significantly reduces pain endured by
osteoarthritis (OA) sufferers, reports Jess...
Combining the sulphur-containing nutrient MSM with well-known joint
health supplement glucosamine appears to speed up the
anti-inflammatory effect and further reduce pain in patients with
osteoarthritis, report Indian researchers.
A licence granting Carolwood Corporation the right to produce
products containing methyl-sulfonyl-methane (MSM) has been revoked
by the product's creator MSM Investments.